These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6675189)

  • 1. The delta agent in acute and chronic hepatitis B infection in Sweden.
    Norkrans G; Hermodsson S; Iwarson S
    Scand J Gastroenterol; 1983 Jul; 18(5):675-8. PubMed ID: 6675189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with delta agent in Sweden: introduction of a new hepatitis agent.
    Hansson BG; Moestrup T; Widell A; Nordenfelt E
    J Infect Dis; 1982 Oct; 146(4):472-8. PubMed ID: 7119477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of delta infection.
    Moestrup T; Hansson BG; Widell A; Nordenfelt E
    Br Med J (Clin Res Ed); 1983 Jan; 286(6359):87-90. PubMed ID: 6401506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
    Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
    Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
    Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
    J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
    Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
    Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta hepatitis in Malaysia.
    Sinniah M; Dimitrakakis M; Tan DS
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic expression of hepatitis B and delta virus antigens in patients with acute and chronic hepatitis.
    Pilleri G; Faa G; Liguori C; Goffi C; Lai E
    Ric Clin Lab; 1985; 15(4):337-42. PubMed ID: 3914698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute delta hepatitis without circulating HBsAg.
    De Cock KM; Govindarajan S; Redeker AG
    Gut; 1985 Feb; 26(2):212-4. PubMed ID: 3967840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.
    Rizzetto M; Purcell RH; Gerin JL
    Lancet; 1980 Jun; 1(8180):1215-8. PubMed ID: 6104036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
    Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
    J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic delta hepatitis: a difficult problem for the hepatologist.
    Picciotto A; Celle G
    Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus.
    Ponzetto A; Seeff LB; Buskell-Bales Z; Ishak KG; Hoofnagle JH; Zimmerman HJ; Purcell RH; Gerin JL
    Hepatology; 1984; 4(6):1111-5. PubMed ID: 6500507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frequency of delta infections in Heidelberg].
    Gmelin K; Theilmann L; Roggendorf M; Wolf P; Schlipköter U; Czygan P; Kommerell B; Deinhardt F
    Klin Wochenschr; 1985 Feb; 63(4):164-7. PubMed ID: 3884893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta agent infection: an unfavourable event in HBsAg positive chronic hepatitis.
    Sagnelli E; Piccinino F; Pasquale G; di Costanzo MG; Franzese R; Peinetti P
    Liver; 1984 Jun; 4(3):170-6. PubMed ID: 6748872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
    Picciotto L; Abrescia N; Ciampi R
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta infection among patients with chronic hepatitis B in the Stockholm region.
    Lindh G; Weiland O; Hansson BG; Svedmyr A
    Infection; 1984; 12(1):27-30. PubMed ID: 6706409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of the role of delta agent infection in children with HBsAg-positive chronic hepatitis.
    Maggiore G; Hadchouel M; Sessa F; Vinci M; Craxì A; Marzani MD; De Giacomo C; Alagille D
    Hepatology; 1985; 5(1):7-9. PubMed ID: 3967866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.